A new treatment to protect young Americans from RSV has received FDA approval, with cold and flu season waiting in the wings. NBC 5 Health and Wellness Reporter Lauren Petty has more details.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA approves new drug to protect babies from RSVThe FDA approved a new drug to protect babies from RSV, the leading cause of hospitalization for U.S. infants.
Leer más »
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonLast year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
Leer más »
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonLast year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
Leer más »
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonU.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year.
Leer más »
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonU.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of...
Leer más »
FDA approves new drug, Beyfortus, to protect toddlers and babies against RSVThe new drug prevents RSV lower respiratory tract disease in infants and children entering or during their first RSV season and is the second monoclonal antibody on the market.
Leer más »